SomaLogic (NASDAQ:SLGC) Rating Lowered to Sell at Zacks Investment Research

SomaLogic (NASDAQ:SLGC – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday, Zacks.com reports. According to Zacks, “SomaLogic Inc. provides AI-data driven proteomics technology. SomaLogic Inc., formerly known as CM Life Sciences II Inc., is based in NEW YORK. […]

Related Keywords

New York ,United States ,Thomson Reuter ,Stifel Nicolaus ,Raymond James Financial Services Advisors Inc ,York State Common Retirement Fund ,Zacks Investment Research ,Commonwealth Equity Services ,Cm Life Sciences Ii Inc ,Somalogic Inc ,Td Asset Management Inc ,Financial Services Group Inc ,Get Rating ,Logic Inc ,Equity Services ,James Financial Services Advisors ,Services Group ,Somalogic ,Nasdaq Slgc ,Slgc ,Business Service ,Downgrade ,